CSF2 and gastric cancer: To further investigate the role of CSF2-mediated reprogramming of MSCs in promoting gastric cancer progression in vivo, we conducted subcutaneous xenograft mouse tumor models with HGC-27 cells together with MSCs from different sources (1:1 ratio).